193 related articles for article (PubMed ID: 38085892)
1. 2021 World Health Organization Classification of Brain Tumors.
Meredith DM; Pisapia DJ
Continuum (Minneap Minn); 2023 Dec; 29(6):1638-1661. PubMed ID: 38085892
[TBL] [Abstract][Full Text] [Related]
2. Updates on the WHO diagnosis of IDH-mutant glioma.
Reuss DE
J Neurooncol; 2023 May; 162(3):461-469. PubMed ID: 36717507
[TBL] [Abstract][Full Text] [Related]
3. Classification and Grading of Central Nervous System Tumors According to the World Health Organization 5th Edition.
Yoda RA; Cimino PJ
Semin Neurol; 2023 Dec; 43(6):833-844. PubMed ID: 37949117
[TBL] [Abstract][Full Text] [Related]
4. The Evolving Classification of Diffuse Gliomas: World Health Organization Updates for 2021.
Perez A; Huse JT
Curr Neurol Neurosci Rep; 2021 Nov; 21(12):67. PubMed ID: 34817712
[TBL] [Abstract][Full Text] [Related]
5. The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors.
Bale TA; Rosenblum MK
Brain Pathol; 2022 Jul; 32(4):e13060. PubMed ID: 35218102
[TBL] [Abstract][Full Text] [Related]
6. [The 2021 WHO Classification of Tumors, 5th edition, Central Nervous System Tumors: A Short Review].
Komori T
Brain Nerve; 2022 Jun; 74(6):803-809. PubMed ID: 35676215
[TBL] [Abstract][Full Text] [Related]
7. [The 2021 WHO classification of tumours of the central nervous system].
Figarella-Branger D; Appay R; Metais A; Tauziède-Espariat A; Colin C; Rousseau A; Varlet P
Ann Pathol; 2022 Oct; 42(5):367-382. PubMed ID: 34865882
[TBL] [Abstract][Full Text] [Related]
8. [World Health Organization Classification of Central Nervous System Tumours, 5
Ichimura K
No Shinkei Geka; 2023 Mar; 51(2):349-363. PubMed ID: 37055056
[TBL] [Abstract][Full Text] [Related]
9. Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors.
Ramkissoon SH; Fernandes H; Lopez-Terrada DH; Hameed MR; Trembath DG; Bridge JA; Lindeman NI; Souers RJ; Vasalos P; Brat DJ; Moncur JT
Arch Pathol Lab Med; 2022 May; 147(5):518-524. PubMed ID: 35878398
[TBL] [Abstract][Full Text] [Related]
10. A review of adult-type diffuse gliomas in the WHO CNS5 classification with special reference to Astrocytoma, IDH-mutant and Oligodendroglioma, IDH-mutant and 1p/19q codeleted.
Santosh V; Rao S
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S14-S23. PubMed ID: 35562130
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system.
Gritsch S; Batchelor TT; Gonzalez Castro LN
Cancer; 2022 Jan; 128(1):47-58. PubMed ID: 34633681
[TBL] [Abstract][Full Text] [Related]
12. World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas: A Review.
Berger TR; Wen PY; Lang-Orsini M; Chukwueke UN
JAMA Oncol; 2022 Oct; 8(10):1493-1501. PubMed ID: 36006639
[TBL] [Abstract][Full Text] [Related]
13. 2021 updates to the World Health Organization classification of adult-type and pediatric-type diffuse gliomas: a clinical practice review.
Thomas DL
Chin Clin Oncol; 2023 Feb; 12(1):7. PubMed ID: 36922356
[TBL] [Abstract][Full Text] [Related]
14. Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline.
Sahm F; Brandner S; Bertero L; Capper D; French PJ; Figarella-Branger D; Giangaspero F; Haberler C; Hegi ME; Kristensen BW; Kurian KM; Preusser M; Tops BBJ; van den Bent M; Wick W; Reifenberger G; Wesseling P
Neuro Oncol; 2023 Oct; 25(10):1731-1749. PubMed ID: 37279174
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of revisions to the WHO classification of diffuse gliomas and associated future problems.
Sonoda Y
Int J Clin Oncol; 2020 Jun; 25(6):1004-1009. PubMed ID: 32020379
[TBL] [Abstract][Full Text] [Related]
16. Review of the Recent Changes in the WHO Classification for Pediatric Brain and Spinal Cord Tumors.
Halfpenny AM; Wood MD
Pediatr Neurosurg; 2023; 58(5):337-355. PubMed ID: 36617415
[TBL] [Abstract][Full Text] [Related]
17. Miscellaneous newly recognized types of CNS tumors in the WHO CNS5 classification (other than gliomas, glioneuronal and embryonal tumors).
Chatterjee D; Gupta K
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S94-S98. PubMed ID: 35562139
[TBL] [Abstract][Full Text] [Related]
18. The 2016 revision of the WHO Classification of Central Nervous System Tumours: retrospective application to a cohort of diffuse gliomas.
Rogers TW; Toor G; Drummond K; Love C; Field K; Asher R; Tsui A; Buckland M; Gonzales M
J Neurooncol; 2018 Mar; 137(1):181-189. PubMed ID: 29218432
[TBL] [Abstract][Full Text] [Related]
19. WHO 2021 and beyond: new types, molecular markers and tools for brain tumor classification.
Tran S; Bielle F
Curr Opin Oncol; 2022 Nov; 34(6):670-675. PubMed ID: 36093875
[TBL] [Abstract][Full Text] [Related]
20. Changes to pediatric brain tumors in 2021 World Health Organization classification of tumors of the central nervous system.
Oztek MA; Noda SM; Romberg EK; Cole BL; Wright JN; Ishak GE; Perez FA
Pediatr Radiol; 2023 Mar; 53(3):523-543. PubMed ID: 36348014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
